CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 372 enrolled
Drug / intervention
Medtronic MiniMed 530G Insulin Pumpdevice
Likely dose
Medtronic MiniMed 530G Insulin Pumpfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02003898
NCT02003898N/ACompleted
CompareCT.gov

Post Approval Study of the TS (Threshold Suspend) Feature With a Sensor-Augmented Pump System Supplemented With Commercial Patient Data

Medtronic MiniMed, Inc.·interventional·Posted Dec 6, 2013·Updated Mar 5, 2019

In Brief

A clinical study evaluating Medtronic MiniMed 530G Insulin Pump for Diabetes. Completed, enrolled 372 participants across 43 sites.

Detailed Summary

The purpose of this study is to evaluate the Threshold Suspend (TS) feature of the Medtronic MiniMed® 530G insulin pump in patients 16 and older with insulin requiring diabetes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedDec 6, 2013
Enrollment StartNov 26, 2013
Primary CompletionFeb 20, 2018
TodayJul 2, 2026
Enrollment to primary: 4.2 yearsPosted 12.6 years ago

Interventions

Medtronic MiniMed 530G Insulin Pumpdevice